These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35533809)

  • 1. Reprogramming neurons for regeneration: The fountain of youth.
    Yang SG; Wang XW; Qian C; Zhou FQ
    Prog Neurobiol; 2022 Jul; 214():102284. PubMed ID: 35533809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells.
    Moad M; Pal D; Hepburn AC; Williamson SC; Wilson L; Lako M; Armstrong L; Hayward SW; Franco OE; Cates JM; Fordham SE; Przyborski S; Carr-Wilkinson J; Robson CN; Heer R
    Eur Urol; 2013 Nov; 64(5):753-61. PubMed ID: 23582880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivation of Endogenous Genes and Epigenetic Remodeling Are Barriers for Generating Transgene-Free Induced Pluripotent Stem Cells in Pig.
    Choi KH; Park JK; Son D; Hwang JY; Lee DK; Ka H; Park J; Lee CK
    PLoS One; 2016; 11(6):e0158046. PubMed ID: 27336671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
    Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in reprogramming somatic cells to induced pluripotent stem cells.
    Patel M; Yang S
    Stem Cell Rev Rep; 2010 Sep; 6(3):367-80. PubMed ID: 20336395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducing goat pluripotent stem cells with four transcription factor mRNAs that activate endogenous promoters.
    Chen H; Zuo Q; Wang Y; Song J; Yang H; Zhang Y; Li B
    BMC Biotechnol; 2017 Feb; 17(1):11. PubMed ID: 28193206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reprogramming cancer cells: back to the future.
    Lang JY; Shi Y; Chin YE
    Oncogene; 2013 May; 32(18):2247-8. PubMed ID: 22869153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue-Restricted Stem Cells as Starting Cell Source for Efficient Generation of Pluripotent Stem Cells: An Overview.
    Sundaravadivelu PK; Raina K; Thool M; Ray A; Joshi JM; Kaveeshwar V; Sudhagar S; Lenka N; Thummer RP
    Adv Exp Med Biol; 2022; 1376():151-180. PubMed ID: 34611861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient genetic reprogramming of unmodified somatic neural progenitors uncovers the essential requirement of Oct4 and Klf4.
    Di Stefano B; Prigione A; Broccoli V
    Stem Cells Dev; 2009 Jun; 18(5):707-16. PubMed ID: 18724799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2.
    Doege CA; Inoue K; Yamashita T; Rhee DB; Travis S; Fujita R; Guarnieri P; Bhagat G; Vanti WB; Shih A; Levine RL; Nik S; Chen EI; Abeliovich A
    Nature; 2012 Aug; 488(7413):652-5. PubMed ID: 22902501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog.
    Moon JH; Yun W; Kim J; Hyeon S; Kang PJ; Park G; Kim A; Oh S; Whang KY; Kim DW; Yoon BS; You S
    Biochem Biophys Res Commun; 2013 Feb; 431(3):444-9. PubMed ID: 23333380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Versatile In Vivo System to Study Myc in Cell Reprogramming.
    Senís E; Mosteiro L; Grimm D; Abad M
    Methods Mol Biol; 2021; 2318():267-279. PubMed ID: 34019296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pluripotency, Differentiation, and Reprogramming: A Gene Expression Dynamics Model with Epigenetic Feedback Regulation.
    Miyamoto T; Furusawa C; Kaneko K
    PLoS Comput Biol; 2015 Aug; 11(8):e1004476. PubMed ID: 26308610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-derived induced pluripotent stem cells for models of cancer and cancer stem cell research.
    Chao HM; Chern E
    J Formos Med Assoc; 2018 Dec; 117(12):1046-1057. PubMed ID: 30172452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
    Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
    J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reprogramming to pluripotency through a somatic stem cell intermediate.
    Marthaler AG; Tiemann U; Araúzo-Bravo MJ; Wu G; Zaehres H; Hyun JK; Han DW; Schöler HR; Tapia N
    PLoS One; 2013; 8(12):e85138. PubMed ID: 24386457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of New Transcription Factors that Can Promote Pluripotent Reprogramming.
    Huang P; Zhu J; Liu Y; Liu G; Zhang R; Li D; Pei D; Zhu P
    Stem Cell Rev Rep; 2021 Dec; 17(6):2223-2234. PubMed ID: 34448118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct Reprogramming of Human Primordial Germ Cells into Induced Pluripotent Stem Cells: Efficient Generation of Genetically Engineered Germ Cells.
    Bazley FA; Liu CF; Yuan X; Hao H; All AH; De Los Angeles A; Zambidis ET; Gearhart JD; Kerr CL
    Stem Cells Dev; 2015 Nov; 24(22):2634-48. PubMed ID: 26154167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unveiling epigenetic regulation in cancer, aging, and rejuvenation with in vivo reprogramming technology.
    Sogabe Y; Seno H; Yamamoto T; Yamada Y
    Cancer Sci; 2018 Sep; 109(9):2641-2650. PubMed ID: 29989289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current understanding and future perspectives of the roles of sirtuins in the reprogramming and differentiation of pluripotent stem cells.
    Hsu YC; Wu YT; Tsai CL; Wei YH
    Exp Biol Med (Maywood); 2018 Mar; 243(6):563-575. PubMed ID: 29557214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.